$30.36
-2.34-7.16%
Last update: Nov 5, 5:09 PM
Definium Therapeutics Inc
DFTXNASDAQ
The average analyst price target for Definium Therapeutics is $64.81, 115.8% above the current price. Of 16 analysts, 16 rate it Buy. Targets range from $25 to $90. The latest change came on Oct 9, 2026, when JP Morgan initiated coverage of Definium Therapeutics with an Overweight rating and a $84 price target.
Price Target Range — 4 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months
